What is Precipio's stock price target for 2024?

0 Wall Street analysts have issued twelve-month price objectives for Precipio's shares. Their PRPO share price targets range from $40.00 to $40.00. On average, they predict the company's stock price to reach $40.00 in the next year. This suggests a possible upside of 545.2% from the stock's current price. View analysts price targets for PRPO or view top-rated stocks among Wall Street analysts .

How have PRPO shares performed in 2024?

Precipio's stock was trading at $6.50 at the start of the year. Since then, PRPO stock has decreased by 4.6% and is now trading at $6.20. View the best growth stocks for 2024 here .

When is Precipio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our PRPO earnings forecast .

How were Precipio's earnings last quarter?

Precipio, Inc. (NASDAQ:PRPO) released its earnings results on Thursday, August, 23rd. The biotechnology company reported ($3.00) EPS for the quarter, missing analysts' consensus estimates of $38.60 by $41.60. The biotechnology company had revenue of $0.82 million for the quarter. Precipio had a negative net margin of 38.51% and a negative trailing twelve-month return on equity of 51.75%.

When did Precipio's stock split?

Precipio shares reverse split on the morning of Friday, September 22nd 2023. The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Precipio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Biocept (BIOC) , Heat Biologics (HTBX) , Portola Pharmaceuticals (PTLA) , iBio (IBIO) , Inovio Pharmaceuticals (INO) , T2 Biosystems (TTOO) , VBI Vaccines (VBIV) , Co-Diagnostics (CODX) , Jaguar Health (JAGX) .

How do I buy shares of Precipio?

Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:PRPO

Precipio (PRPO) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free PRPO Stock Alerts

$6.20

-0.50 (-7.46%)

(As of 04/19/2024 ET)

Compare

Today's Range: $6.20
▼
$6.67
50-Day Range: $6.00
▼
$6.84
52-Week Range: $4.75
▼
$14.80

Volume: 1,663 shs
Average Volume: 6,367 shs
Market Capitalization: $8.87 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $40.00

Get Precipio alerts:

Precipio MarketRank™ Stock Analysis

Analyst Rating: 0.00 Rating Score
Upside/Downside: 545.2% Upside
$40.00 Price Target
Short Interest: Healthy
0.39% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.00
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.34 out of 5 stars

2.0

Analyst's Opinion

Amount of Analyst Coverage
Precipio has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.39% of the float of Precipio has been sold short.
Short Interest Ratio / Days to Cover
Precipio has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Precipio has recently increased by 6.00%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Precipio does not currently pay a dividend.
Dividend Growth
Precipio does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for PRPO.

0.0

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 2 news articles for Precipio this week, compared to 0 articles on an average week.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Precipio insiders have not sold or bought any company stock.
Percentage Held by Insiders
10.60% of the stock of Precipio is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 10.45% of the stock of Precipio is held by institutions.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Precipio is -1.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Precipio is -1.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Precipio has a P/B Ratio of 0.61. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Precipio Stock (NASDAQ:PRPO)

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.

PRPO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PRPO Stock News Headlines

April 19, 2024 | morningstar.com

Precipio Inc PRPO

April 16, 2024 | americanbankingnews.com

Precipio (NASDAQ:PRPO) Stock Price Crosses Below 200-Day Moving Average of $6.62

April 20, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

March 25, 2024 | globenewswire.com

Precipio Announces Year end 2023 Shareholder Update Call

March 12, 2024 | ca.finance.yahoo.com

Precipio, Inc. (PRPO)

February 23, 2024 | benzinga.com

Precipio Stock (NASDAQ:PRPO), Analyst Ratings, Price Targets, Predictions

February 13, 2024 | finance.yahoo.com

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

February 6, 2024 | finanznachrichten.de

Precipio, Inc.: Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen Portfolio of Molecular assays for Cancer

April 20, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

January 23, 2024 | msn.com

Precipio’s Q4 cash burn from operations drops below $100K for full quarter

January 23, 2024 | finanznachrichten.de

Precipio, Inc.: Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

January 23, 2024 | finance.yahoo.com

Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

January 17, 2024 | finanznachrichten.de

Precipio, Inc.: Precipio Signs Distribution Agreement For IV-Cell and HemeScreen in Japan

January 17, 2024 | finance.yahoo.com

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

January 2, 2024 | finance.yahoo.com

Precipio Announces Christina Valauri joins the Board of Directors

December 15, 2023 | finanznachrichten.de

Precipio, Inc.: Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

December 14, 2023 | finance.yahoo.com

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

October 18, 2023 | finance.yahoo.com

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

October 3, 2023 | finanznachrichten.de

Precipio, Inc.: Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

October 3, 2023 | finance.yahoo.com

Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

September 28, 2023 | finance.yahoo.com

Precipio Continues to Sign New HemeScreen™ Customers

September 25, 2023 | finance.yahoo.com

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

September 22, 2023 | finanznachrichten.de

Precipio, Inc.: Precipio Takes Final Step Towards Regaining Nasdaq Compliance

September 13, 2023 | finance.yahoo.com

Precipio’s Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

August 20, 2023 | finance.yahoo.com

Broker Revenue Forecasts For Precipio, Inc. (NASDAQ:PRPO) Are Surging Higher

August 19, 2023 | finance.yahoo.com

Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript

August 16, 2023 | benzinga.com

Precipio's Earnings: A Preview

See More Headlines

Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/23/2018
Today: 4/20/2024
Next Earnings (Estimated): 5/10/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Analytical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:PRPO
CUSIP: N/A
CIK: 1043961
Web: www.precipiodx.com
Phone: (203) 787-7888
Fax: 402-452-5401
Employees: 51
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $40.00
High Stock Price Target: $40.00
Low Stock Price Target: $40.00
Potential Upside/Downside: +545.2%
Consensus Rating
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($4.56)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-5,850,000.00
Net Margins: -38.51%
Pretax Margin: -38.51%
Return on Equity: -51.75%
Return on Assets: -37.93%

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 1.17
Quick Ratio: 1.05

Sales & Book Value

Annual Sales: $15.20 million
Price / Sales: 0.58
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $10.16 per share
Price / Book: 0.61

Miscellaneous

Outstanding Shares: 1,430,000
Free Float: 1,278,000
Market Cap: $8.87 million
Optionable: Optionable
Beta: 1.61

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Ilan Danieli (Age 52)
Founder, President, CEO & Director
Comp: $324.1k
Dr. Ayman A. Mohamed M.D. (Age 39)
Chief Technology Officer
Comp: $234.1k
Mr. Matthew Gage (Age 57)
Chief Financial Officer
Mr. Ahmed Zaki Sabet (Age 37)
Chief Operating Officer
Comp: $229.03k
Ms. Miri Chiko-Radomski
Chief Legal Counsel & People Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

PRPO Stock Analysis - Frequently Asked Questions

What is Precipio's stock price target for 2024?: 0 Wall Street analysts have issued twelve-month price objectives for Precipio's shares. Their PRPO share price targets range from $40.00 to $40.00. On average, they predict the company's stock price to reach $40.00 in the next year. This suggests a possible upside of 545.2% from the stock's current price.
View analysts price targets for PRPO or view top-rated stocks among Wall Street analysts.
How have PRPO shares performed in 2024?: Precipio's stock was trading at $6.50 at the start of the year. Since then, PRPO stock has decreased by 4.6% and is now trading at $6.20.
View the best growth stocks for 2024 here.
When is Precipio's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our PRPO earnings forecast.
How were Precipio's earnings last quarter?: Precipio, Inc. (NASDAQ:PRPO) released its earnings results on Thursday, August, 23rd. The biotechnology company reported ($3.00) EPS for the quarter, missing analysts' consensus estimates of $38.60 by $41.60. The biotechnology company had revenue of $0.82 million for the quarter. Precipio had a negative net margin of 38.51% and a negative trailing twelve-month return on equity of 51.75%.

When did Precipio's stock split?: Precipio shares reverse split on the morning of Friday, September 22nd 2023. The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.
What other stocks do shareholders of Precipio own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Biocept (BIOC), Heat Biologics (HTBX), Portola Pharmaceuticals (PTLA), iBio (IBIO), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Co-Diagnostics (CODX), Jaguar Health (JAGX).
How do I buy shares of Precipio?: Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PRPO) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial